FDA
approval
· 2022-01-11
FDA Approved: OXCARBAZEPINE — Original Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approved Camber Pharmaceuticals' original ANDA for oxcarbazepine, a generic anticonvulsant indicated for partial seizures.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)